Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REDUCIBLE: Anticoagulation Duration After AF Ablation
NCT03573037Unknown
- Start
- Jul 2014
- Primary completion
- Jun 2020
- Countries
- 1
01
Overview
Randomised, open-label trial in Atrial fibrillation (AFib) (2 arms). Primary endpoint: Thromboembolic event at 6 months. Status: unknown.
02
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03573037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03573037.